Dr. Mark F Kozloff MD
Hematologist-Oncologist | Hematology & Oncology
71 W 156th St Suite 401 Harvey IL, 60426About
Dr. Mark Kozloff is a hematologist oncologist practicing in Harvey, IL. Dr. Kozloff specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Univ of Mi Med Sch, Ann Arbor Mi 1972
University of Michigan Medical School 1972
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- A phase II study of ABT-751 in patients with advanced non-small cell lung cancer.
- Safety and efficacy of combining sunitinib with bevacizumab + paclitaxel/carboplatin in non-small cell lung cancer.
- Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort study.
- Platinol (CDDP) and continuous intravenous infusion 5-fluorouracil in refractory stage IV breast cancer: a phase II study.
- A phase 1B study of dulanermin in combination with modified FOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer.
- TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial.
- Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).
- Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).
- Intracavitary bleomycin for the control of malignant effusions.
- Multimodality therapy of stage III adenocarcinoma of the breast.
- Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapy.
- Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast.
- Acute nephrotoxicity following cis-dichlorodiammine-platinum.
- Melphalan, vincristine, and 5-FU in advanced colonic carcinoma: results of a pilot study.
Clinical Trials
Treatments
- Pancreatic Cancer
- Prostate Cancer
- Anemia
- Breast Cancer
- Lung Cancer
- Anal Cancer
- Colon Cancer
- Lymphoma
- Thyroid Cancer
- Aerolase® Technologies
- Extra Corporeal Shockwave Therapy
Dr. Mark F Kozloff MD's Practice location
Dr. Mark F Kozloff MD's reviews
Write ReviewPatient Experience with Dr. Kozloff
Recommended Articles
- Tips on How to Live with Multiple Myeloma
Multiple myeloma, a type of cancer, adversely affects plasma cells, which are your immune system’s components. The American Cancer Society indicates that in 2014, more than 24,000 people in the United States had multiple myeloma.Multiple myeloma patients can lose their appetite due to the adverse...
- Morphos Declared a "Breakthrough Therapy" for Lymphoma
MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
- Seven-year-old Lymphoma Ninja Warrior Fights Through 500 Days of Chemo
In some ways, Von Kleiv is an ordinary 7-year-old boy. He goes to Welch Elementary School in Dover, Delaware. He’s in second grade. He’s getting into karate, and just broke his first wooden board at his first demonstration. People know him as a boy warrior with a strong spirit. He is optimistic,...
- Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research
There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...
- Exercise Proven to Help Lymphoma Patients
People always say that exercise is the best medicine. It's been proven through many years of research that regular exercise is really important to maintain a healthy body and mind. Doctors are always reminding their patients of the benefits of physical exercise and the power it holds to fight...
- How Immunotherapy Makes a Real Difference in Relapsed Hodgkin Lymphoma
Hodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...
Nearby Providers
- Dr. Alexander Starr MD71 W 156th St Harvey IL 60426
- Dr. Donne bennett De leon Caces M.D., PH.D.71 W 156TH ST HARVEY IL 60426